Avastin/Lucentis Update 53: Latest Information on Contaminated Re-Packaged Avastin

Last Summer and Fall, I wrote two reports on the contaminated re-packaged Avastin that caused severe eye problems in some patients that received intravitreal injections for the treatment of their wet form of AMD (Avastin/Lucentis Updates 48 & 49).

This year, with all of the news about the meningitis outbreak, including several dozen deaths, caused by non-sterile compounding of a drug to treat back pain by a so-called compounding pharmacy, located in my home state of Massachusetts, and with a report presented at this year’s AAO Meeting about the contaminated Avastin from a Florida compounding facility that caused (Read more...)

Full Story →